07 June 2021 | News
The company aims to achieve the benefits of listing the equity shares on the stock exchanges and carry out 'Offer of Sale' of up to 3.57 crore equity shares
Vijaya Diagnostic Centre has filed Draft Red Hearing Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI).
Through the initial public issue, the company aims to achieve the benefits of listing the equity shares on the stock exchanges and carry out 'Offer of Sale' of up to 3.57 crore (3,56,88,064) equity shares by the selling shareholders.
The ‘Offer for Sale’ comprises up to 0.51 crore (50,98,296) equity shares by DS Surendranath Reddy (Promoter Selling Shareholder), up to 2.95 crore (2,94,87,290) equity shares by Karakoram and up to 0.11 crore (11,02,478) equity shares by Kedaara Capital Alternative Investment Fund- Kedaara Capital AIF 1. The face value of equity share is Rs 1 each. The company will not receive any proceeds from the offer.
ICICI Securities, Edelweiss Financial Services and Kotak Mahindra Capital Company are the Book Running Lead Managers to the issue.